J. Vansteenkiste (Leuven, Belgium), P. E. Postmus (Amsterdam, The Netherlands)
Interval change in prevalence and survival from lung cancer in the west of Ireland N. Naji, M. Uzbeck, S. Deady, J. J. Gilmartin (Co. Galway, Cork, Ireland)
| |
Costs of initial bronchoscopic treatment (IBT) in resectable bronchial carcinoids (BC) H. A. P. Brokx, T. G. Sutedja, P. E. Postmus (Amsterdam, Netherlands)
| |
Clinicopathological features of synchronously arisen multiple bronchioloalveolar carcinomas K. Kishi, T. Hujii, A. Kurosaki, M. Mun, T. Kohno, K. Yoshimura (Tokyo, Japan)
| |
Narrow band imaging with high resolution bronchovideoscopy: a new approach to visualize angiogenesis in squamous cell carcinoma of the lung K. Shibuya, T. Nakajima, K. Yasufuku, A. Iyoda, M. Suzuki, Y. Sekine, T. Iizasa, K. Hiroshima, Y. Nakatani, T. Fujisawa (Chiba, Japan)
| |
Endobronchial ultrasound and PET positive nodes in bronchial carcinoma J. Faber, P. Pierard, T. Prigogine, M. Dusart, A. Haller, T. Bosschaerts, J. P. Sculier, V. Ninane (Brussels, Belgium)
| |
EBUS-TBNA for mediastinal restaging M. Krasnik, A. Ernst, R. Eberhardt, K. Yasufuku, F. Herth (Copenhagen, Denmark; Boston, United States Of America; Heidelberg, Germany; Chiba, Japan)
| |
Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) K. E. Pat, P. R. De Leyn, S. G. Stroobants, W. F. M. De Wever, J. F. Vansteenkiste (Leuven, Belgium)
| |
Effect of vascular endothelial growth factor antisense oligonucleotides and low molecular weight heparin on pulmonary thromboembolism in mice with Lewis lung cancer Y. Zhang, C. Wang, Z. Zhai (Beijing, China)
| |